Back
Acumen Pharmaceuticals Vs. Akoya Biosciences Industry Stock Comparison
Buy
52
ABOS
Acumen Pharmaceuticals
Last Price:
3.48
Seasonality Move:
68.9%
Sell
25
AKYA
Akoya Biosciences
Last Price:
4.01
Seasonality Move:
1.37%
Buy
52
Acumen Pharmaceuticals (ABOS)
is a Buy
Is Acumen Pharmaceuticals a Buy, Sell or Hold?
- The current Acumen Pharmaceuticals [ABOS] share price is $3.48. The Score for ABOS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ABOS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Akoya Biosciences (AKYA)
is a Sell
Is Akoya Biosciences a Buy, Sell or Hold?
- The current Akoya Biosciences [AKYA] share price is $3.99. The Score for AKYA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AKYA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABOS Stock Price Chart
What is Acumen Pharmaceuticals's stock price today?
-
The Acumen Pharmaceuticals share price today is $3.48
The current trend is relatively stagnant and ABOS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKYA Stock Price Chart
What is Akoya Biosciences's stock price today?
-
The Akoya Biosciences share price today is $3.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKYA is experiencing slight selling pressure.
ABOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 49.32 | Sell |
| Chaikin Money Flow: | 229426 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.21 - 3.85) | Sell |
| Bollinger Bands (100): | (3.14 - 4.1) | Sell |
AKYA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 42.31 | Sell |
| Chaikin Money Flow: | -6462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.83 - 4.35) | Sell |
| Bollinger Bands (100): | (4.23 - 5.45) | Sell |
ABOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.23 | Buy |
| 20-day SMA: | 3.43 | Buy |
| 50-day SMA: | 3.84 | Sell |
| 200-day SMA: | 4.11 | Sell |
| 8-day EMA: | 3.29 | Buy |
| 20-day EMA: | 3.42 | Buy |
| 50-day EMA: | 3.6 | Sell |
| 200-day EMA: | 4 | Sell |
AKYA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Buy |
| 20-day SMA: | 4 | Sell |
| 50-day SMA: | 4.62 | Sell |
| 200-day SMA: | 4.81 | Sell |
| 8-day EMA: | 3.9 | Buy |
| 20-day EMA: | 4.04 | Sell |
| 50-day EMA: | 4.42 | Sell |
| 200-day EMA: | 5.27 | Sell |
Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.15 per share.
Akoya Biosciences Earnings Growth & AKYA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.63 per share, and an increase next year of $0.31 per share.
Acumen Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akoya Biosciences Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||